Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 12.4337 | 99 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 12.4701 | 99 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 12.496 | 99 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 12.7147 | 99 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 12.6806 | 99 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 12.7128 | 99 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 12.3939 | 99 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 12.5129 | 99 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 12.2637 | 99 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 12.2808 | 99 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 12.6607 | 99 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 12.7652 | 99 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 12.6321 | 99 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 12.5826 | 99 |